Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006

被引:38
|
作者
Goldacre, Michael J. [1 ]
Duncan, Marie [1 ]
Griffith, Myfanwy [1 ]
Turner, Martin R. [2 ]
机构
[1] Univ Oxford, Dept Publ Hlth, Unit Health Care Epidemiol, Oxford OX3 7LF, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
关键词
Multiple sclerosis; Motor neuron disease; Parkinson's disease; Epilepsy; Mortality; Trends; MORTALITY-RATES; MORBIDITY;
D O I
10.1007/s00415-009-5392-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this study is to report trends in mortality, as certified on death certificates, from multiple sclerosis (MS), motor neuron disease (MND), primary Parkinson's disease (PD), and epilepsy, analysing not only the underlying cause of death but also all certified causes for each disease. Death records in the Oxford region, 1979-2006, and England, 1996-2006, were analysed for ascertaining the trends in mortality. The percentage of deaths coded as the underlying cause changed over time, coinciding with changes to the rules for selecting the underlying cause of death. Changes over time to coding rules had a large impact on apparent trends in death rates for PD when studied by underlying cause alone. They also had significant, though smaller, effects on trends in death rates for MS, MND and epilepsy. Nationally, in the last period of the study, underlying cause mortality identified 64% of deaths with a mention of MS, 88% of MND, 56% of PD, and 48% of epilepsy. In the longstanding Oxford data from 1979 to 2006, death rates based on all certified causes of death showed no significant change for MS; an upward trend for MND (notably in women over 75), though only in the last few years of the study; a significant but small decline for PD; and no significant change for epilepsy. When mortality statistics are analysed by underlying cause only, their value is reduced. A substantial percentage of neurological deaths are missed. Time trends may be misleading. All certified causes for each disease, as well as the underlying cause, should be analysed.
引用
收藏
页码:706 / 715
页数:10
相关论文
共 50 条
  • [41] Unexpected aggravation of Parkinson’s disease by a mesencephalic multiple sclerosis lesion
    Alexandre Kreisler
    Bruno Stankoff
    Maria João Ribeiro
    Yves Agid
    Catherine Lubetzki
    Bertrand Fontaine
    Journal of Neurology, 2004, 251 : 1526 - 1527
  • [42] Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis
    Alimonti, Alessandro
    Ristori, Giovanni
    Giubilei, Franco
    Stazi, Maria Antonia
    Pino, Anna
    Visconti, Andrea
    Brescianini, Sonia
    Monti, Micaela Sepe
    Forte, Giovanni
    Stanzione, Paolo
    Bocca, Beatrice
    Bomboi, Giuseppe
    D'Ippolito, Cristina
    Annibali, Viviana
    Salvetti, Marco
    Sancesario, Giuseppe
    NEUROTOXICOLOGY, 2007, 28 (03) : 450 - 456
  • [43] The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer's, and Parkinson's disease'
    Cantero-Fortiz, Yahveth
    Boada, Merce
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [44] Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis
    Li-Yuan Fan
    Jing Yang
    Ruo-Yu Liu
    Ying Kong
    Guang-Yu Guo
    Yu-Ming Xu
    Journal of Translational Medicine, 21
  • [45] Pain in Parkinson's disease and multiple sclerosis: Its relation to the medial and lateral pain systems
    Scherder, E
    Wolters, E
    Polman, C
    Sergeant, J
    Swaab, D
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2005, 29 (07) : 1047 - 1056
  • [46] A SYSTEMATIC REVIEW OF CASE-IDENTIFICATION ALGORITHMS BASED ON ITALIAN HEALTHCARE ADMINISTRATIVE DATABASES FOR THREE RELEVANT DISEASES OF THE NERVOUS SYSTEM: PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, AND EPILEPSY
    Canova, Cristina
    Danieli, Silvia
    Amidei, Claudio Barbiellini
    Simonato, Lorenzo
    Di Domenicantonio, Riccardo
    Cappai, Giovanna
    Bargagli, Anna Maria
    EPIDEMIOLOGIA & PREVENZIONE, 2019, 43 (04): : 62 - 74
  • [47] Practice recommendations for psychological interventions in neurological rehabilitation: multiple sclerosis, Parkinson's disease and stroke
    Kampting, Hanna
    Kuest, Jutta
    Allert, Niels
    Dettmers, Christian
    Mittag, Oskar
    ZEITSCHRIFT FUR NEUROPSYCHOLOGIE, 2019, 30 (01) : 45 - 47
  • [48] Mobile App Interventions for Parkinson's Disease, Multiple Sclerosis and Stroke: A Systematic Literature Review
    Triantafyllidis, Andreas
    Segkouli, Sofia
    Zygouris, Stelios
    Michailidou, Christina
    Avgerinakis, Konstantinos
    Fappa, Evangelia
    Vassiliades, Sophia
    Bougea, Anastasia
    Papagiannakis, Nikos
    Katakis, Ioannis
    Mathioudis, Evangelos
    Sorici, Alexandru
    Bajenaru, Lidia
    Tageo, Valentina
    Camonita, Francesco
    Magga-Nteve, Christoniki
    Vrochidis, Stefanos
    Pedulla, Ludovico
    Brichetto, Giampaolo
    Tsakanikas, Panagiotis
    Votis, Konstantinos
    Tzovaras, Dimitrios
    SENSORS, 2023, 23 (07)
  • [49] Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis
    Fan, Li-Yuan
    Yang, Jing
    Liu, Ruo-Yu
    Kong, Ying
    Guo, Guang-Yu
    Xu, Yu-Ming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [50] Parkinson's disease-associated parkin colocalizes with Alzheimer's disease and multiple sclerosis brain lesions
    Witte, Maarten E.
    Bol, John G. J. M.
    Gerritsen, Wouter H.
    van der Valk, Paul
    Drukarch, Benjamin
    van Horssen, Jack
    Wilhelmus, Micha M. M.
    NEUROBIOLOGY OF DISEASE, 2009, 36 (03) : 445 - 452